Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review).

[1]  Martin McKee,et al.  Priority actions for the non-communicable disease crisis , 2011, The Lancet.

[2]  T. Vos,et al.  Cost-effectiveness of interventions to reduce dietary salt intake , 2010, Heart.

[3]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[4]  G. MacGregor,et al.  Reducing population salt intake worldwide: from evidence to implementation. , 2010, Progress in cardiovascular diseases.

[5]  M. Alderman.  Reducing dietary sodium: the case for caution. , 2010, JAMA.

[6]  F. Cappuccio,et al.  Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies , 2009, BMJ : British Medical Journal.

[7]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[8]  F. Sarullo,et al.  Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend? , 2008, Clinical science.

[9]  N. Cook,et al.  Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP) , 2007, BMJ : British Medical Journal.

[10]  Hsing-Yi Chang,et al.  Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men. , 2006, The American journal of clinical nutrition.

[11]  S. Ebrahim,et al.  Advice to reduce dietary salt for prevention of cardiovascular disease. , 2004, The Cochrane database of systematic reviews.

[12]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[13]  Jiang He,et al.  Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. , 2002, JAMA.

[14]  S. Thompson,et al.  How should meta‐regression analyses be undertaken and interpreted? , 2002, Statistics in medicine.

[15]  P. Whelton,et al.  Commentary: Salt intake, hypertension and risk of cardiovascular disease: an important public health challenge , 2002 .

[16]  Alan C. Wilson,et al.  Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). , 2001, Archives of internal medicine.

[17]  G. MacGregor,et al.  Effect of longer-term modest salt reduction on blood pressure. , 2000, The Cochrane database of systematic reviews.

[18]  P. Whelton,et al.  Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. , 2000, Hypertension.

[19]  F. Cappuccio.  Sodium, Potassium, Calcium and Magnesium and Cardiovascular Risk , 2000, Journal of cardiovascular risk.

[20]  P. Whelton,et al.  Predictors and mediators of successful long-term withdrawal from antihypertensive medications. TONE Cooperative Research Group. Trial of Nonpharmacologic Interventions in the Elderly. , 1999, Archives of family medicine.

[21]  L. Appel,et al.  Does withdrawal of antihypertensive medication increase the risk of cardiovascular events? Trial of Nonpharmacologic Interventions in the Elderly (TONE) Cooperative Research Group. , 1998, The American journal of cardiology.

[22]  N. Cook,et al.  Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. , 1998, Hypertension.

[23]  N. Cook,et al.  Effect of change in sodium excretion on change in blood pressure corrected for measurement error. The Trials of Hypertension Prevention, Phase I. , 1998, American journal of epidemiology.

[24]  P. Whelton,et al.  Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. , 1998, JAMA.

[25]  George Davey Smith,et al.  Meta-analysis: Principles and procedures , 1997, BMJ.

[26]  P. Whelton,et al.  Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE) , 1997 .

[27]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[28]  N. Cook,et al.  Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group. , 1997, The American journal of clinical nutrition.

[29]  Alan C. Wilson,et al.  Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE) , 1997, Journal of the American Geriatrics Society.

[30]  P. Elliott,et al.  Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations , 1996 .

[31]  N. Borhani,et al.  Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure. Results from Phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. , 1995, Annals of epidemiology.

[32]  N. Borhani,et al.  Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Trials of Hypertension Prevention (TOHP) Collaborative Research Group. , 1995, Annals of epidemiology.

[33]  Alan C. Wilson,et al.  Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. , 1995, Annals of epidemiology.

[34]  N. Cook,et al.  Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (phase II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. , 1995, Annals of epidemiology.

[35]  N. Borhani,et al.  Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. , 1995, Annals of epidemiology.

[36]  N. Cook,et al.  The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. , 1995, Annals of epidemiology.

[37]  V. Stevens,et al.  Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group. , 1995, Annals of epidemiology.

[38]  J. Cutler,et al.  Short report : the effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the trials of hypertension prevention , 1994 .

[39]  N. Cook,et al.  Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research Group. , 1993, Hypertension.

[40]  N. Cook,et al.  Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group. , 1993, Archives of internal medicine.

[41]  C. McHorney,et al.  The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.

[42]  P. Whelton,et al.  Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention. , 1992, Annals of epidemiology.

[43]  N. Cook,et al.  The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal Levels: Results of the Trials of Hypertension Prevention, Phase I , 1992 .

[44]  J. Cutler,et al.  Trials of hypertension prevention. Phase I design. , 1991, Annals of epidemiology.

[45]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[46]  R. Jeffery,et al.  Hypertension Prevention Trial (HPT): food pattern changes resulting from intervention on sodium, potassium, and energy intake. Hypertension Prevention Trial Research Group. , 1990, Journal of the American Dietetic Association.

[47]  R. Jeffery,et al.  Hypertension prevention trial: do 24-h food records capture usual eating behavior in a dietary change study? , 1990, The American journal of clinical nutrition.

[48]  N. Borhani,et al.  Design, methods, and rationale in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group. , 1989, Controlled clinical trials.

[49]  M. V. Van Natta,et al.  Baseline characteristics in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group. , 1989, Controlled clinical trials.

[50]  N. Borhani,et al.  Recruitment in the Hypertension Prevention trial. Hypertension Prevention Trial Research Group. , 1989, Controlled clinical trials.

[51]  S. Tonascia,et al.  Treatment in the Hypertension Prevention Trial , 1989 .

[52]  J. Cutler,et al.  Quality assurance and monitoring in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group. , 1989, Controlled clinical trials.

[53]  Paul L. Canner,et al.  Quality assurance and monitoring in the Hypertension Prevention Trial , 1989 .

[54]  N. Borhani,et al.  Recruitment in the Hypertension Prevention Trial , 1989 .

[55]  J. Forster,et al.  Baseline characteristics in the Hypertension Prevention Trial , 1989 .

[56]  Hammond Jj.  Failure of therapy to improve prognosis in elderly males with hypertension. , 1980, The Medical journal of Australia.

[57]  R. Gibberd,et al.  FAILURE OF THERAPY TO IMPROVE PROGNOSIS IN ELDERLY MALES WITH HYPERTENSION , 1980, The Medical journal of Australia.

[58]  Trefor Owen Morgan,et al.  HYPERTENSION TREATED BY SALT RESTRICTION , 1978, The Lancet.

[59]  R. A. Baker,et al.  MEDICINE IN THE OPEN UNIVERSITY , 1975, The Lancet.

[60]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration , 2013 .

[61]  N. Cook,et al.  Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II , 2005, Journal of Human Hypertension.

[62]  G. Jürgens,et al.  Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. , 2003, The Cochrane database of systematic reviews.

[63]  P. Whelton,et al.  Salt intake, hypertension and risk of cardiovascular disease: an important public health challenge. , 2002, International journal of epidemiology.

[64]  J. Stamler,et al.  Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. , 1996, BMJ.

[65]  P. Elliott.  Sodium and blood pressure: a review of the evidence from controlled trials of sodium reduction and epidemiological studies. , 1991, Klinische Wochenschrift.

[66]  S. Corrigan,et al.  Demographic, knowledge, physiological, and behavioral variables as predictors of compliance with dietary treatment goals in hypertension. , 1991, Addictive behaviors.

[67]  R. Jeffery,et al.  Attributions for dietary failures: problems reported by participants in the Hypertension Prevention Trial. , 1990, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[68]  The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Hypertension Prevention Trial Research Group. , 1990, Archives of internal medicine.